Abstract
Healthcare workers have a greater exposure to individuals with confirmed SARS-novel coronavirus 2, and thus a higher probability of contracting coronavirus disease (CoViD)-19, than the general population. Employers have a duty of care to minimise the risk for their employees. We wished to explore the predictive role of basic demographics in order to establish a simple tool that could help risk stratify healthcare workers.
Methods We undertook a review of the published literature (including multiple search strategies in MEDLINE with PubMed interface) and critically assessed early reports on medRxiv, a pre-print server (https://www.medrxiv.org: date of last search: May 18, 2020). We explored the relative risk of mortality from readily available demographics in order to identify the population at highest risk and incorporated them into a biological risk assessment tool.
Results There were a multitude of international studies exploring the predictors of adverse outcomes in the general population. Two UK based datasources were identified that predicted admission to ITU and mortality in the UK population. Mortality increased with increasing age from 50 years onwards. Male sex at birth and people of black and minority ethnicity groups had higher susceptibility to both hospitalisation and mortality. Similarly, vascular disease, diabetes and chronic pulmonary disease further increased risk.
A risk stratification tool was compiled using a Caucasian female <50years of age with no comorbidities as a reference. Each point allocated to risk factors was associated with an approximate doubling in risk. This tool provides objective support for employers when determining which healthcare workers should be allocated to high-risk vs. lower risk patient facing clinical duties or to remote supportive roles.
Conclusions We have generated a tool which can provide a framework for objective risk stratification of doctors and health care professionals during the CoViD-19 pandemic.
Strengths and limitations of this study
There is potentially an increased risk of mortality in the clinical workforce due to the effects of CoViD-19.
This manuscript outlines a simple risk stratification tool that helps to quantify an individual’s biological risk
This will assist team leaders when allocating roles within clinical departments.
This tool does not incorporate other external factors, such as high-risk household members or those at higher risk of mental health issues, that may require additional consideration when allocating clinical duties in an appropriate clinical domain.
This population-based analysis did not explain for the very high risk observed in BAME healthcare workers suggesting there are other issues at play that require addressing.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
There is no new data - this represents an analysis of published data
